National Cancer Institute, Research Contracts Branch, PCCS, 6120 Executive Blvd, Room 635, Bethesda, MD 20892-7226

A -- PHASE II-CLINICAL TRIALS OF NEW CHEMOPREVENTIVE AGENTS SOL MAA-N01-CN-75023-82 DUE 070797 POC Michelle L. Scala, Contract Specialist, 301-435-3829 E-MAIL: Michelle L. Scala, scalam@rcb.nci.nih.gov. This synopsis was advertised in the CBD on April 8, 1997. This synopsis is amended because the solicitation will NOT be available electronically, instead it will be mailed on or about April 28, 1997. Following proposal submission and the initial technical review process, offerors whose proposals were judged ACCEPTABLE will be awarded an MA; they will then be eligible to compete for work as Master Agreement Order (MAO) RFP's are issued. Responses to the MAA/RFP will be due on or about July 7, 1997. Point of contact: Michelle L. Scala, Contract Specialist; Electronic mail address: scalam@rcb.nci.nih.gov; Telephone: (301) 435- 3829; Fax: (301) 402-8579. All requests should reference N01-CN-75023-82. All responsible sources may submit a proposal, which shall be considered by the agency. No collect calls will be accepted. NUMBERED NOTES: Note 26 (0112)

Loren Data Corp. http://www.ld.com (SYN# 0008 19970424\A-0008.SOL)